Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-25-000867
Filing Date
2025-02-14
Accepted
2025-02-14 17:01:23
Documents
2
Period of Report
2025-02-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4773
2 POWER OF ATTORNEY exh_24.htm EX-24 5196
  Complete submission text file 0001171843-25-000867.txt   11415
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address
Marshall Patrick (Reporting) CIK: 0001978257 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37619 | Film No.: 25630575